Neuphoria therapeutics to ring the nasdaq opening bell on march 3rd, 2025

Burlington, mass., march 03, 2025 (globe newswire) -- neuphoria therapeutics inc. (nasdaq: neup) (neuphoria or company), ”), a clinical-stage biotechnology developing impactful treatments for neuropsychiatric disorders, bringing new hope and tangible improvements to patients' lives, announced today that it will ring the opening bell at the nasdaq marketsite in times square, new york city on monday, march 3rd, 2025.
NDAQ Ratings Summary
NDAQ Quant Ranking